Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 0 | 14 | 28 |
| Gross Profit | N/A | N/A | N/A | 14 | 28 |
| Operating Expenses | 9,467 | 12,286 | 9,865 | 11,031 | 8,407 |
| Operating Income | -9,467 | -12,286 | -9,865 | -11,017 | -8,379 |
| Other Income | 235 | 193 | 119 | -8 | -29 |
| Pre-tax Income | -9,232 | -12,093 | -9,746 | -11,025 | -8,408 |
| Net Income Continuous | -9,232 | -12,093 | -9,746 | -11,025 | -8,408 |
| Net Income | $-9,218 | $-12,093 | $-9,746 | $-11,025 | $-8,408 |
| EPS Basic Total Ops | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 |
| EPS Basic Continuous Ops | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 |
| EPS Diluted Total Ops | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 |
| EPS Diluted Continuous Ops | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.60 | -0.50 | N/A | N/A |
| EBITDA(a) | $-9,461 | $-12,271 | $-9,841 | $-10,983 | $-8,334 |